Interplay Between Statutes of Repose and Statutes of Limitations in Latent Disease Exposure Claims

Start
As toxic tort claims alleging chronic illness from alleged chemical exposure continue to rise nationwide, the recent Kansas federal court decision in Jefferies v. Harcros Chemicals Inc., 2026 WL 958172, (April 9, 2026), highlights the power of statutes of repose, which can bar latent disease claims, even when the injury is discovered decades after exposure….
By: Faegre Drinker Biddle & Reath LLP
Previous Story

Supreme Court Grapples with Roundup®, Federal Preemption, and the Limits of EPA Authority

Next Story

AI in Aviation: Is a Patent Owner Liable?